---ADDS SHARE PRICE MOVE---
AquaBounty Technologies (LON:ABTU, OTC: AQBT) shares made a splash as its genetically enhanced salmon received a boost today after a Canada court ruling endorsed the government's decision there to allow production of the fish for commercial use.
The Federal Court of Canada also dismissed an application brought by the Ecology Action Centre and Living Oceans Society.
Shares in the biotech group added over 31% in London to 29.5p each.
The court ruled that the Ministers of Environment and Health decision to allow production of AquAdvantage Salmon in Canada for commercial use was "reasonable and made in the manner prescribed by the Canadian Environmental Protection Act, 1999.."
Aquabounty chief executive Ronald L. Stotish, said: "We are delighted but not surprised that the Federal Court of Canada has agreed with the Ministers of Environment and Health of Canada that our salmon eggs are not harmful to the environment or human health when produced in contained facilities.
"This should allay any remaining fears consumers may have about our fish. The ruling also affirms that Canada has one of the most stringent regulatory systems in the world."
It comes after last month, the US Food and Drug Administration (FDA) approved the group's genetically enhanced salmon for production, sale and consumption.
The so-called AquAdvantage Salmon is an Atlantic salmon enhanced to reach market size in less time than a conventionally farmed fish.
"We are motivated by our desire to bring to market the most sustainably raised, healthy and nutritious food to consumers and to satisfy the needs of an ever-increasing population. This decision will allow us to move forward to deliver this goal," Stotish added today.